Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Samsung Biologics Reports First Quarter 2024 Financial Results 2024-04-24 14:45
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab) 2024-04-24 09:27
LG Energy Solution to Take Firm Stance Against Patent Infringers 2024-04-24 07:13
Visionary Holdings Inc. Announcement of Management Change 2024-04-24 07:00
Tungray Technologies Inc Announces Closing of Initial Public Offering 2024-04-23 23:08
MultiMetaVerse Holdings Limited Receives Nasdaq Notification Regarding Minimum Bid Price and Minimum Market Value of Listed Securities 2024-04-23 21:20
Lufax Announces Annual General Meeting on May 30, 2024 and Filing of Its Annual Report on Form 20-F 2024-04-23 21:05
Zepp Health Corporation Files 2023 Annual Report on Form 20-F 2024-04-23 20:20
Delta Unveils Groundbreaking Solutions for Smart Manufacturing and e-Mobility at Hannover Messe 2024 2024-04-23 19:20
OneConnect Files Annual Report on Form 20-F 2024-04-23 19:04
Yalla Group Limited Files 2023 Annual Report on Form 20-F 2024-04-23 18:50
OSR Holdings and SillaJen have entered into a Memorandum of Understanding to collaboratively pursue the development of innovative therapeutics and enter the U.S. market 2024-04-23 18:37
Aquaron Acquisition Corp. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-K 2024-04-23 18:30
HUYA Inc. to Report First Quarter 2024 Financial Results on Monday, May 13, 2024 2024-04-23 18:00
Emeren Group and Nuveen Infrastructure Finalize 354 MWp Battery Storage Portfolio in Italy with 2.83 GWh Capacity 2024-04-23 18:00
Cango Inc. Announces Up to US$50 Million New Share Repurchase Program 2024-04-23 18:00
JinkoSolar to supply Nyox Srl with 100MW Tiger Neo modules 2024-04-23 17:09
LG Display to Mass Produce World's First Gaming OLED Panel With Switchable Refresh Rate and Resolution 2024-04-23 09:00
PharmAbcine's U.S. Subsidiary, Wincal Biopharm, to Present Preclinical Data from its Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024 2024-04-23 07:25
Lufax Reports First Quarter 2024 Financial Results 2024-04-23 05:30
1 294 295 296 297 298 2426